Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
TerrAscend Corp ( (TSE:TSND) ) has issued an update.
TerrAscend Corp has announced the acquisition of Ratio Cannabis LLC, marking its entry into Ohio, its sixth U.S. state. This acquisition is expected to enhance TerrAscend’s financial performance immediately and expand its retail presence to 39 dispensaries across North America. The company plans to further expand its footprint in Ohio by acquiring additional dispensaries, aiming to reach the state limit of eight. This strategic move is significant for TerrAscend’s growth and positioning in the competitive cannabis industry, especially given the legal complexities of operating in the U.S. market.
Spark’s Take on TSE:TSND Stock
According to Spark, TipRanks’ AI Analyst, TSE:TSND is a Neutral.
TerrAscend Corp exhibits moderate potential with strengths in cash flow improvements and strategic expansion in New Jersey. However, the company faces significant challenges in profitability and valuation due to high liabilities and negative earnings. Technical indicators show moderate momentum, but valuation concerns remain due to the lack of profitability.
To see Spark’s full report on TSE:TSND stock, click here.
More about TerrAscend Corp
TerrAscend is a leading North American cannabis company with operations in Pennsylvania, New Jersey, Maryland, Michigan, and California, as well as retail operations in Canada. The company operates several dispensary brands, including The Apothecarium and Gage, and is involved in cultivation, processing, and manufacturing, providing products to both medical and adult-use markets.
Average Trading Volume: 170,859
Technical Sentiment Signal: Sell
Current Market Cap: C$196.1M
For a thorough assessment of TSND stock, go to TipRanks’ Stock Analysis page.